99% Purity CAS 36703-88-5 Isoprinosine Pharmaceutical Intermediate Chemical Isoprinosine Powder Material Isoprinosine

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Adult
• State: Powder
• Purity: >99%
• Model NO.: Dsung-Isoprinosine
• Product Name: Isoprinosine
• Name: Isoprinosine Powder
• Appearance: White Powder
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical Intermediate
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 36703-88-5
• Molecular Formula: C52h78n10o17
• MW: 1115.23000
• Boiling Point: 732.8 C at 760 Mmhg
• Psa: 403.10000
• Logp: 1.76610
• Specification: 99%
• Trademark: D-Sung
• Origin: Shaanxi
• Production Capacity: 500kg/Month

Product Description

99% Purity CAS 36703-88-5 Isoprinosine Pharmaceutical Intermediate Chemical Isoprinosine Powder Material Isoprinosine

 

Product Description

Product Details

Product Name	Isoprinosine
CAS No.	36703-88-5
Purity	99%
MW	1115.23000
Appearance and shape	White powder

Isoprinosine is a kind of immunomodulatory drugs, in vitro test proved that it can enhance the immune response of PHA or antigen, and promote the differentiation and proliferation of T lymphocytes, and can be triggered by TH cells or macrophages and stimulate the B lymphocyte differentiation and produce antibodies. In the body has antiviral and anticancer activity, double-blind clinical trials show that isopropyl inosine oral can reduce various virus infection (such as the flu, chicken pox, measles, mumps and multiple stomatitis, etc.) the duration and severity of disease.

Application & Function

1. For a variety of viral infections, including subacute sclerosing panencephalitis, acute viral meningitis, herpes zoster, skin herpes, influenza and thrush, herpesvirus keratitis, uveitis, acquired immunity Defect syndrome (AIDS), immunodeficiency disease and so on.
2. As a therapeutic agent for malignant lymphoma, myeloma, early malignant melanoma, combined with surgery for the treatment of esophageal cancer, gastric cancer, rectal cancer, thyroid cancer patients.

Specification